Western Blotting Processors Market Snapshot
As per a recently updated report by Future Market Insights (FMI), the global western blotting processors market size was valued at US$ 223.0 Mn in 2020 and is expected to reach a market valuation of more than US$ 235.5 Mn in 2021.
Growth predictions in North America remain positive owing to the increasing use of western blotting processors in various diagnostic procedures. The rising incidence of bovine spongiform encephalopathy (BSE), feline immunodeficiency virus (FIV), and hepatitis B diseases is giving tailwinds to growth in the U.S. Spurred by this, North America is expected to account for 35.0% of the global market in 2031.
The market registered 4.20% CAGR between 2016 and 2020. Growth trends are forecast to remain positive, enabling it to surpass US$ 383.7 Mn in valuation by 2031.
Key Points Covered In Western Blotting Processors Market Research
- Market Estimates And Forecast 2021 - 2031
- Key drivers and restraints impacting the market growth
- Segment wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand share and Market share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Western Blotting Processors Market And How to Navigate
- Recommendations on Key Winning Strategies
Western Blotting Processors Market Future Outlook Brighter In Comparison To Historic Growth
The global western blotting processors market is likely to surpass US$ 235.5 Mn in 2021. It is expected to grow at a steady pace during the forecast period 2021-2031.
Increasing adoption of automated dry blotting systems under product segment is anticipated to drive the market growth. Demand for automated systems will continue rising owing to their ability to analyze various samples in a single trial. Through this, they enable minimizing the processing time and averting all the physical tasks except sample loading into the western blotting system.
Medical diagnostics devices employed for identifying specific protein molecules from a composite mixture of protein samples in genetic science and proteomics is expected to fuel the market growth in the assessment period.
Key players operating in the market are adopting strategies of expansion, mergers & acquisitions and new product innovations to enhance their market position.
For instance, In June 2019, Thermo Fisher Scientific, a key manufacturer of scientific instruments, chemicals consumables and services to healthcare, announced the launch of its new product, iBright 1500 Imaging System Series for western blot and gel imaging.
Features including, automatic zoom, focus, sample rotation, high-resolution 9.1- megapixel camera are intended to help scientists identify subtle differences in samples and chemiluminescent blot to conduct their research efficaciously. This launch aided in expanding the product portfolio of the company.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Demand for Improved Accuracy in Diagnostics Spurring Western Blotting Processors Sales
Western blotting with the help of western blotting processors is an analytical technique used to separate and detect specific proteins from a complex protein sample. Proteins are separated by Western blotting processors based on molecular weight of proteins, which form bands on a gel and are then transferred onto a nitrocellulose or polyvinylidene fluoride membrane.
The steps performed by western blotting processors are tissue preparation to antibody-based detection of proteins. Western blotting processors find application in a wide variety of fields, where the large contribution is through the diagnostics market.
The western blotting processors market is in the mature stage in developed countries, where use of automatic western blotting processors systems is more or less consistent to maintain the efficiency of the outcomes.
As the incidence of HIV is increasing across the globe, western blotting technique including western blotting processors are expected to gain popularity over the forecast period.
Western blotting processors are time-consuming instruments for the detection of protein molecules. One of the major reasons for the growing adoption of automated western blotting processors is the traditional ones requiring manpower for completion of protocol.
The later western blotting processors technique demands continuous supervision, thus manpower is mandatory while performing this method manually to enhance reproducibility.
Automated western blotting processors perform steps such as mixing of solution, washing of gel, and hence reduce the time required for protocol by using multifunctional reagents.
For research purposes in developing countries, traditional western blotting processors still widely used due to non-availability of resources and affordability issues. In terms of revenue, the global western blotting processors market is projected to grow at a CAGR of 5.1% during the forecast period and is expected to be valued at US$ 328.6 Mn by the end of 2028.
The Asia-Pacific, China and Japan markets for western blotting processors are expected to witness significant growth in the global western blotting processors market over the forecast period.
The global western blotting processors market is segmented into six major regions, namely North America, Latin America, Europe, Asia Pacific (Asia-Pacific excluding China and Japan), China, Japan and Middle East & Africa (MEA). In terms of value, North America is expected to be the dominant regional market for western blotting processors by 2018 end and is expected to expand at a CAGR of 5.2% over the forecast period in western blotting processors usage.
The Asia Pacific, China and Japan are expected to be the fast-growing regional markets for western blotting processors in terms of revenue in the global western blotting processors market, registering CAGRs of 5.7%, 6.8% and 6.1%, respectively, over the forecast period.
In North America, the U.S. is expected to be the dominant market for western blotting processors due to increasing incidence of HIV, BSE, FIV, and hepatitis B infections. According to the U.S. Department of Health & Human Services, 39,782 people received an HIV diagnosis in 2016.
Availability of cost-effective, rapid diagnosis using western blotting processors is also a factor expected to drive the growth of the western blotting processors market in the U.S. over the forecast period.
The second dominant regional market for western blotting processors is Western Europe due to an increase in healthcare expenditure and funding by the government. In addition, there are several manufacturers present in the region, which address to an increasingly competitive market. The favourable reimbursement policies by the government for disease diagnosis are also expected to drive the growth of the market for western blotting processors in the region.
The growing research and development investments by companies to bring innovations in devices is also expected to fuel the growth of the western blotting processors. The adoption of western blotting processors has increased in APCJ, which is expected to drive the growth of the market for western blotting processors in the region.
According to the statistics provided by the WHO, the prevalence of HSV-2 has increased and is generally higher among women than among men in the Pacific, Southeast Asia and South Asia with 0.3 Mn, 33.2 Mn and 27.5 Mn, respectively. In addition, growing funding for agriculture research in India and ASEAN countries is also expected to drive the growth of the market for western blotting processors over the forecast period.
Key Questions Answered in the Report
What is the Western Blotting Processors Market Size?
Western blotting processors market was valued at US$ 223.0 Mn in 2020 and is likely to reach a valuation of US$ 235 Mn in 2021.
At What Rate Did the Western Blotting Processors Market Grow in the Last Five Years?
The western blotting processors market exhibited growth at 4.20% CAGR between 2016 and 2020.
What is the Market Share of Top Players in Western Blotting Processors Market?
The combined market share of top players, including Bio-Rad Laboratories, Inc, Thermo Fisher Scientific, GE Healthcare stood at 90% of the overall market.
Which are the Top 5 Countries Driving Western Blotting Processors Demand?
The U.S., Brazil, China, Japan and India are the top five countries driving western blotting processors demand.
What is the North America Western Blotting Processors Market Outlook?
The demand in North America will continue to rise, owing to the availability of cutting-edge healthcare infrastructure. As per FMI, North America market will account for 35.0% of global sales by 2031.
At What Percentage will the Western Blotting Processors Market Grow in Europe?
The Europe market is likely to grow at an average annual rate of 4.9% in 2021.
Which Countries are Key Producers of Western Blotting Processors?
The U.S., the U.K., and Japan are key producers of western blotting processors.
Which Companies are Key Exporters of Western Blotting Processors Market?
Bio-Rad Laboratories, Inc, Thermo Fisher Scientific, GE Healthcare, Bio-Techne Corporation, Merck KGaA, PerkinElmer Inc, Endress+Hauser Management AG, Gen Script Biotech Corporation, Expedeon AG, ATTO Corporation are key exporters of western blotting processors.
What is Driving Demand for Western Blotting Processors?
Increasing adoption of western blot as the standard test in the detection of anti-HIV antibodies in blood serum samples is driving the market growth.
What are the Key Statistics for Western Blotting Processors in China and Japan?
China and Japan will account for 7.1% and 6.1% respectively of the global western blotting processors market in 2021.
By Product Type:
- Automated Dry Blotting Systems
- Semi-Dry Blotting Systems
- Traditional Wet Transfer Blotting Systems
- Agricultural Application
- Food & Beverages
- Medical Diagnostics
- Scientific Research
- Other Applications
By End Users:
- Diagnostic laboratories
- Pharmaceutical and Biotechnology Companies
- Research & Academic institution
- North America
- Latin America
- Rest of Latin America
- Western Europe
- Rest of Western Europe
- Eastern Europe
- Rest of Eastern Europe
- Asia Pacific excluding China & Japan
- Australia & New Zealand
- Rest of Asia- Pacific excluding China & Japan
- GCC Countries
- South Africa
- Rest of MEA